Literature DB >> 16751073

Intensity-modulated radiotherapy in patients with locally advanced rectal cancer reduces volume of bowel treated to high dose levels.

M Teresa Guerrero Urbano1, Anthony J Henrys, Elisabeth J Adams, Andrew R Norman, James L Bedford, Kevin J Harrington, Christopher M Nutting, David P Dearnaley, Diana M Tait.   

Abstract

PURPOSE: To investigate the potential for intensity-modulated radiotherapy (IMRT) to spare the bowel in rectal tumors. METHODS AND MATERIALS: The targets (pelvic nodal and rectal volumes), bowel, and bladder were outlined in 5 patients. All had conventional, three-dimensional conformal RT and forward-planned multisegment three-field IMRT plans compared with inverse-planned simultaneous integrated boost nine-field equally spaced IMRT plans. Equally spaced seven-field and five-field and five-field, customized, segmented IMRT plans were also evaluated.
RESULTS: Ninety-five percent of the prescribed dose covered at least 95% of both planning target volumes using all but the conventional plan (mean primary and pelvic planning target volume receiving 95% of the prescribed dose was 32.8 +/- 13.7 Gy and 23.7 +/- 4.87 Gy, respectively), reflecting a significant lack of coverage. The three-field forward planned IMRT plans reduced the volume of bowel irradiated to 45 Gy and 50 Gy by 26% +/- 16% and 42% +/- 27% compared with three-dimensional conformal RT. Additional reductions to 69 +/- 51 cm(3) to 45 Gy and 20 +/- 21 cm(3) to 50 Gy were obtained with the nine-field equally spaced IMRT plans-64% +/- 11% and 64% +/- 20% reductions compared with three-dimensional conformal RT. Reducing the number of beams and customizing the angles for the five-field equally spaced IMRT plan did not significantly reduce bowel sparing.
CONCLUSION: The bowel volume irradiated to 45 Gy and 50 Gy was significantly reduced with IMRT, which could potentially lead to less bowel toxicity. Reducing the number of beams did not reduce bowel sparing and the five-field customized segmented IMRT plan is a reasonable technique to be tested in clinical trials.

Entities:  

Mesh:

Year:  2006        PMID: 16751073     DOI: 10.1016/j.ijrobp.2005.12.056

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  54 in total

Review 1.  Volumetric modulated arc therapy: a review of current literature and clinical use in practice.

Authors:  M Teoh; C H Clark; K Wood; S Whitaker; A Nisbet
Journal:  Br J Radiol       Date:  2011-11       Impact factor: 3.039

2.  A treatment planning study of prone vs. supine positions for locally advanced rectal carcinoma : Comparison of 3‑dimensional conformal radiotherapy, tomotherapy, volumetric modulated arc therapy, and intensity-modulated radiotherapy.

Authors:  Sergiu Scobioala; Christopher Kittel; Philipp Niermann; Heidi Wolters; Katharina Helene Susek; Uwe Haverkamp; Hans Theodor Eich
Journal:  Strahlenther Onkol       Date:  2018-05-31       Impact factor: 3.621

Review 3.  Current treatment of rectal cancer adapted to the individual patient.

Authors:  Laura Cerezo; Juan Pablo Ciria; Leire Arbea; Olga Liñán; Sergio Cafiero; Vincenzo Valentini; Francesco Cellini
Journal:  Rep Pract Oncol Radiother       Date:  2013-10-03

4.  Cone-beam computed tomography for organ motion evaluation in locally advanced rectal cancer patients.

Authors:  Consuelo Rosa; Luciana Caravatta; Monica Di Tommaso; David Fasciolo; Lucrezia Gasparini; Fiorella Cristina Di Guglielmo; Antonietta Augurio; Annamaria Vinciguerra; Claudio Vecchi; Domenico Genovesi
Journal:  Radiol Med       Date:  2020-04-15       Impact factor: 3.469

Review 5.  Radiation-induced small bowel disease: latest developments and clinical guidance.

Authors:  Rhodri Stacey; John T Green
Journal:  Ther Adv Chronic Dis       Date:  2014-01       Impact factor: 5.091

Review 6.  Rectal cancer treatment: improving the picture.

Authors:  Juan A Diaz-Gonzalez; Leire Arbea; Javier Aristu
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

7.  Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): dosimetric comparison and clinical implications.

Authors:  Leire Arbea; Luis Isaac Ramos; Rafael Martínez-Monge; Marta Moreno; Javier Aristu
Journal:  Radiat Oncol       Date:  2010-02-26       Impact factor: 3.481

Review 8.  Intensity-modulated radiation therapy for gastrointestinal tumors.

Authors:  Jeffrey J Meyer; Brian G Czito; Christopher G Willett
Journal:  Curr Oncol Rep       Date:  2008-05       Impact factor: 5.075

9.  Preoperative chemoradiotherapy in the management of localized rectal cancer: the new standard.

Authors:  Theodore S Hong; Lisa A Kachnic
Journal:  Gastrointest Cancer Res       Date:  2007-03

10.  Impact of (18)F-FDG-PET/CT on staging and irradiation of patients with locally advanced rectal cancer.

Authors:  Brigita Paskeviciute; Tobias Bölling; Markus Brinkmann; Ganna Rudykina; Iris Ernst; Lars Stegger; Otmar Schober; Normann Willich; Matthias Weckesser; Stefan Könemann
Journal:  Strahlenther Onkol       Date:  2009-04-16       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.